From Doctor to Patient, Building a Better Bridge to Healing

No matter which field it sits in, a successful business often demonstrates a number of common characteristics. It understands its market and serves an unflagging need within it. It provides its clients with a product or service in a manner that meet or exceed standards set by competitors. It employs a business strategy that accommodates the present and plans for the future. It balances the wants of its customers with the operational procedures required for financial success. From publishing to automotives, ventures in any industry thrive or flounder given these factors. Today, we turn to an exemplary firm in healthcare.

Established in 2003, OncoMed Pharmaceuticals upholds a multi-tiered mission. The group, which provides prescription items to treat afflictions within hematology and oncology, maintains a close relationship with all involved parties. OncoMed deals closely with manufacturers to ensure the easiest possible distribution and subsequent timely allotment to patients, offers patients resources that reduce personal costs and personalize care plans, supports managed-care groups to best deliver oncological treatment platforms, and works with physicians to minimize obstacles. Headquartered in Great Neck, New York, OncoMed supervises locations throughout Pennsylvania and Massachusetts. It will soon open venues in nine other states, including California, Texas, Michigan, Arizona, and Kentucky. At the head of the rapidly expanding venture and its efforts to revolutionize the pharmaceuticals arena sit a number of seasoned executives. Scott Feigeles, Director of Pharmacy, formerly acted as Chief of Staff Pharmacist and Purchasing Director for Choice Drugs, a group that serves more than 20,000 hospital beds throughout the New York Metropolitan area. Ellen Scharaga, Senior Vice President of Pharmacy Operations, upheld administrative positions with six pharmaceutical companies in a career that spans nearly 30 years. Thanks to Ellen Scharaga and others, OncoMed continues to improve turn-around time on prescriptions, build relationships with more physicians and care providers, and ultimately serve more individuals coping with cancers.